Morgan Stanley China A Share Fund Inc (CAF) 19.20

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Morgan Stanley China A Share Fund Inc (CAF) 19.20 $CAF

Morgan Stanley China A Share Fund Shares Down 23.3% Since SmarTrend's Sell Call (CAF)
Comtex SmarTrend(R) - Thu Feb 04, 12:58PM CST
SmarTrend identified a Downtrend for Morgan Stanley China A Share Fund (NYSE:CAF) on December 29th, 2015 at $20.41. In approximately 1 month, Morgan Stanley China A Share Fund has returned 23.32% as of today's recent price of $15.65.
CAF: 19.20 (+0.15)

Downtrend Call Working As Morgan Stanley China A Share Fund Stock Falls 24.7% (CAF)
Comtex SmarTrend(R) - Thu Jan 28, 10:40AM CST
SmarTrend identified a Downtrend for Morgan Stanley China A Share Fund (NYSE:CAF) on December 29th, 2015 at $20.41. In approximately 1 month, Morgan Stanley China A Share Fund has returned 24.69% as of today's recent price of $15.37.
CAF: 19.20 (+0.15)

Shares of CAF Down 22.1% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Thu Jan 21, 9:40AM CST
SmarTrend identified a Downtrend for Morgan Stanley China A Share Fund (NYSE:CAF) on December 29th, 2015 at $20.41. In approximately 3 weeks, Morgan Stanley China A Share Fund has returned 22.15% as of today's recent price of $15.89.
CAF: 19.20 (+0.15)

Morgan Stanley China A Share Fund Down 18.2% Since SmarTrend Downtrend Call (CAF)
Comtex SmarTrend(R) - Wed Jan 13, 10:19AM CST
SmarTrend identified a Downtrend for Morgan Stanley China A Share Fund (NYSE:CAF) on December 29th, 2015 at $20.41. In approximately 2 weeks, Morgan Stanley China A Share Fund has returned 18.18% as of today's recent price of $16.70.
CAF: 19.20 (+0.15)

-18.9% Return Seen to Date on SmarTrend Morgan Stanley China A Share Fund Call (CAF)
Comtex SmarTrend(R) - Tue Dec 29, 10:47AM CST
SmarTrend identified an Uptrend for Morgan Stanley China A Share Fund (NYSE:CAF) on October 20th, 2015 at $25.26. In approximately 2 months, Morgan Stanley China A Share Fund has returned 18.87% as of today's recent price of $20.49.
CAF: 19.20 (+0.15)

Morgan Stanley China A Share Fund, Inc. Declares a Dividend
BusinessWire - Tue Dec 08, 3:30PM CST
The Morgan Stanley China A Share Fund, Inc. (the "Fund" today declared the following dividend.
CAF: 19.20 (+0.15)

Morgan Stanley China A Share Fund, Inc. Announces Ability to Invest Through Stock Connect
BusinessWire - Fri Nov 13, 3:30PM CST
Morgan Stanley China A Share Fund, Inc. (NYSE:CAF) (the "Fund" announced today that it may invest in China A-shares through the Shanghai-Hong Kong Stock Connect Program ("Stock Connect".
CAF: 19.20 (+0.15)

Morgan Stanley China A Share Fund Has Returned 25.4% Since SmarTrend Recommendation (CAF)
Comtex SmarTrend(R) - Mon Oct 19, 9:32AM CDT
SmarTrend identified a Downtrend for Morgan Stanley China A Share Fund (NYSE:CAF) on June 19th, 2015 at $33.61. In approximately 4 months, Morgan Stanley China A Share Fund has returned 25.37% as of today's recent price of $25.08.
CAF: 19.20 (+0.15)

28.8% Return Seen to Date on SmarTrend Morgan Stanley China A Share Fund Call (CAF)
Comtex SmarTrend(R) - Fri Oct 09, 5:30PM CDT
SmarTrend identified a Downtrend for Morgan Stanley China A Share Fund (NYSE:CAF) on June 19th, 2015 at $33.61. In approximately 4 months, Morgan Stanley China A Share Fund has returned 28.82% as of today's recent price of $23.92.
CAF: 19.20 (+0.15)

Morgan Stanley China A Share Fund Down 30.8% Since SmarTrend Downtrend Call (CAF)
Comtex SmarTrend(R) - Fri Oct 02, 4:58PM CDT
SmarTrend identified a Downtrend for Morgan Stanley China A Share Fund (NYSE:CAF) on June 19th, 2015 at $33.61. In approximately 4 months, Morgan Stanley China A Share Fund has returned 30.75% as of today's recent price of $23.27.
CAF: 19.20 (+0.15)

Morgan Stanley China A Share Fund Down 27.1% Since SmarTrend Downtrend Call (CAF)
Comtex SmarTrend(R) - Fri Sep 11, 9:53AM CDT
SmarTrend identified a Downtrend for Morgan Stanley China A Share Fund (NYSE:CAF) on June 19th, 2015 at $33.61. In approximately 3 months, Morgan Stanley China A Share Fund has returned 27.09% as of today's recent price of $24.50.
CAF: 19.20 (+0.15)

Morgan Stanley China A Share Fund Shares Down 11.9% Since SmarTrend's Sell Call (CAF)
Comtex SmarTrend(R) - Thu Aug 13, 10:25AM CDT
SmarTrend identified a Downtrend for Morgan Stanley China A Share Fund (NYSE:CAF) on June 19th, 2015 at $33.61. In approximately 2 months, Morgan Stanley China A Share Fund has returned 11.92% as of today's recent price of $29.60.
CAF: 19.20 (+0.15)

Morgan Stanley China A Share Fund Has Returned 16.3% Since SmarTrend Recommendation (CAF)
Comtex SmarTrend(R) - Tue Jul 28, 9:43AM CDT
SmarTrend identified a Downtrend for Morgan Stanley China A Share Fund (NYSE:CAF) on June 19th, 2015 at $33.61. In approximately 1 month, Morgan Stanley China A Share Fund has returned 16.32% as of today's recent price of $28.12.
CAF: 19.20 (+0.15)

10.7% Return Seen to Date on SmarTrend Morgan Stanley China A Share Fund Call (CAF)
Comtex SmarTrend(R) - Thu Jul 09, 9:20AM CDT
SmarTrend identified a Downtrend for Morgan Stanley China A Share Fund (NYSE:CAF) on June 19th, 2015 at $33.61. In approximately 3 weeks, Morgan Stanley China A Share Fund has returned 10.73% as of today's recent price of $30.00.
CAF: 19.20 (+0.15)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading

Top 5 Most Recently Viewed Articles

Celcuity Inc. Prepares for Third Quarter Financial Results

Updated Category News Views 91

Celcuity Inc. Announces Upcoming Financial Results Release Celcuity Inc. (NASDAQ: CELC), a pioneering biotechnology company focused on innovative oncology therapies, has exciting news. The company will be releasing its financial results for the third quarter of 2025 after the market closes. This significant event is scheduled for a Wednesday, with management set to...

Continue Reading
EverTrue and DonorSearch Team Up to Revolutionize Fundraising

Updated Category News Views 973

EverTrue's Strategic Acquisition of DonorSearch EverTrue, a leader in donor engagement and pipeline development, recently announced a significant acquisition. The company has acquired DonorSearch, known for its innovative AI-powered donor discovery solutions. This strategic move is aimed at enhancing the capabilities of fundraising teams, enabling them to connect with...

Continue Reading
Celebrating Creativity and Inclusion: ADCOLOR Awards 2025

Updated Category News Views 315

ADCOLOR Awards 2025: A Night of Inspiration and Celebration Presented by leading organizations in the industry like Amazon, Disney, and Meta, the ADCOLOR Awards is a prestigious event celebrating remarkable individuals and organizations that champion diversity and inclusion in creative fields. This year's ceremony showcased inspiring figures such as Richelieu Dennis,...

Continue Reading
Transforming a $1000 Investment in First Solar to $3700

Updated Category News Views 161

Transform Your Investment with First Solar First Solar (NASDAQ: FSLR) has shown impressive performance over the past decade. This company has not only managed to keep pace with the market but has actually outperformed it by an average of 2.49% annually. This impressive annualized return translates to an average annual growth of 14.22%, making First Solar a notable player...

Continue Reading
Carpenter Technology Announces New Quarterly Dividend Plans

Updated Category News Views 107

Carpenter Technology Announces Quarterly Cash Dividend Carpenter Technology Corporation (NYSE: CRS), a leading name in high-performance specialty alloys, has made a significant announcement regarding its quarterly cash dividend. The company's Board of Directors has declared a dividend of $0.20 per share on common stock, underscoring its commitment to returning value to...

Continue Reading